Developing drugs targeting CX3CL1 to treat heart diseases via immune/inflammatory mediation.

ABSTRACT:

SUBMITTER: Zou L 

PROVIDER: S-EPMC10577471 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature